Qrons Stock Price, News & Analysis
Company Description
Qrons (OTC Link: QRON) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $1.2M.
QRON stock has declined 93.2% over the past year. Shares last traded at $0.0111.
On a trailing twelve-month basis, Qrons reported revenue of $0 with net income of -$56K and diluted earnings per share of $0.00.
This page provides a comprehensive overview of QRON stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Qrons (QRON) stock last traded at $0.0111. Over the past 12 months, the stock has lost 93.2%. At a market capitalization of $1.2M, QRON is classified as a micro-cap stock with approximately 17.9M shares outstanding.
Latest News
Qrons has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include management, clinical trial. View all QRON news →
SEC Filings
Qrons has filed 1 recent SEC filing, including 1 Form 8-K. The most recent filing was submitted on April 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all QRON SEC filings →
Financial Highlights
operating income reached -$344K, and net income was -$56K. Diluted earnings per share stood at $0.00. The company generated -$62K in operating cash flow. With a current ratio of 0.00, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
QRON Company Profile & Sector Positioning
Qrons (QRON) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing QRON often look at related companies in the same sector, including Biocure Technolo (BICTF), Regen Biopharma (RGBPP), Halberd Corp (HALB), Evofem Bioscienc (EVFM), and Ayala Pharm (ADXS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate QRON's relative position within its industry.